Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

about

HIV Trafficking Between Blood and Semen During Early Untreated HIV Infection.

P2860

Q39466748-945514C8-6D3C-4E12-828E-01BE47E62C40

P2860

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

Item

http://www.wikidata.org/entity/Q36756170

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

@ast

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

@en

type

Item

label

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

@ast

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

@en

prefLabel

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

@ast

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

@en

P1476

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

@en

P2093

Carolina Herrera

http://www.w3.org/2001/XMLSchema#string

Naomi Armanasco

http://www.w3.org/2001/XMLSchema#string

Patricia Fletcher

http://www.w3.org/2001/XMLSchema#string

P2860

Microbicides: topical prevention against HIV

Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex

Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs

Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor

Early events in sexual transmission of HIV and SIV and opportunities for interventions.

A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection.

Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.

Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.

Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.

P304

334-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/AID.2015.0315

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy Nuttall

Robin Shattock

P577

2016-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26711323

http://www.w3.org/2001/XMLSchema#string

P932

4817569

http://www.w3.org/2001/XMLSchema#string

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

about

P2860

P2860

Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932